|
1
|
Hanna E, DeMonte F, Ibrahim S, Roberts D,
Levine N and Kupferman M: Endoscopic resection of sinonasal cancers
with and without craniotomy: Oncologic results. Arch Otolaryngol
Head Neck Surg. 135:1219–1224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Szablewski V, Neuville A, Terrier P, Laé
M, Schaub R, Garrel R, Coindre JM and Costes V: Adult sinonasal
soft tissue sarcoma: Analysis of 48 cases from the French Sarcoma
Group database. Laryngoscope. 125:615–623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson SM, Duque CS, Sheth RN, Casiano
RR, Morcos JJ and Gomez-Fernandez CR: Case report: Liposarcoma of
the sinonasal tract. Br J Radiol. 82:e160–e163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fletcher CD, Bridge JA, Hogendoorn PCW and
Mertens F: WHO Classification of Tumors of Soft Tissue and Bone.
4th. IARC; Lyon: 2013
|
|
5
|
Gritli S, Khamassi K, Lachkhem A, Touati
S, Chorfa A, Ben Makhlouf T, El May A and Gammoudi A: Head and neck
liposarcomas: A 32 year experience. Auris Nasus Larynx. 37:347–351.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Henricks AH, Chu YC, Goldblum JR and Weiss
SW: Dedifferentiated liposarcoma: A clinicopathological analysis of
155 cases with aproposal for an expanded definition of
dedifferentiation. Am J Surg Pathol. 21:271–281. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Guellec S, Chibon F, Ouali M, Perot G,
Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM and
Neuville A: Are peripheral purely undifferentiated pleomorphic
sarcomas with MDM2 amplification dedifferentiated liposarcomas? Am
J Surg Pathol. 38:293–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de la Roza G, Baredes S and Aisner SC:
Dedifferentiated liposarcoma of the cheek. Ann Diagn Pathol.
8:352–357. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Makeieff M, Pelliccia P, Poizat F, Arnaud
S, Rat F, Cupissol D, Guerrier B and Costes V: Laryngeal
dedifferentiated liposarcoma. Eur Arch Otorhinolaryngol.
267:991–994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zreik R, Soyalp K, Ruiz S, Ward R, Dobin
S, Chen X, Liu L and Rao A: Ultrasound-guided fine-needle
aspiration of a posterior neck dedifferentiated liposarcoma with
MDM2 fluorescence in situ hybridization performed on a Pap-stained
smear. Diagn Cytopathol. 43:320–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Evans HL: Liposarcoma: A study of 55 cases
with a reassessment of its classification. Am J Surg Pathol.
3:507–523. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCormick D, Mentzel T, Beham A and
Fletcher CD: Dedifferentiated liposarcoma. Clinicopathologic
analysis of 32 cases suggesting a better prognostic subgroup among
pleomorphic sarcomas. Am J Surg Pathol. 18:1213–1223. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Binh MB, Sastre-Garau X, Guillou L, de
Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I and Coindre JM:
MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing
well-differentiated and dedifferentiated liposarcoma subtypes: A
comparative analysis of 559 soft tissue neoplasms with genetic
data. Am J Surg Pathol. 29:1340–1347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sandberg AA: Updates on the cytogenetics
and molecular genetics of bone and soft tissue tumors: Liposarcoma.
Cancer Genet Cytogenet. 155:1–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sirvent N, Coindre JM, Maire G, Hostein I,
Keslair F, Guillou L, Ranchere-Vince D, Terrier P and Pedeutour F:
Detection of MDM2-CDK4 amplification by fluorescence in situ
hybridization in 200 paraffin-embedded tumor samples: Utility in
diagnosing adipocytic lesions and comparison with
immunohistochemistry and real-time PCR. Am J Surg Pathol.
31:1476–1489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ragazzini P, Gamberi G, Pazzaglia L, Serra
M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M,
Bertoni F, et al: Amplification of CDK4, MDM2, SAS and GLI genes in
leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol
Histopathol. 19:401–411. 2004.PubMed/NCBI
|
|
17
|
Wallander ML, Tripp S and Layfield LJ:
MDM2 amplification in malignant peripheral nerve sheath tumors
correlates with p53 protein expression. Arch Pathol Lab Med.
136:95–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ito M, Barys L, O'Reilly T, Young S,
Gorbatcheva B, Monahan J, Zumstein-Mecker S, Choong PF, Dickinson
I, Crowe P, et al: Comprehensive mapping of p53 pathway alterations
reveals an apparent role for both SNP309 and MDM2 amplification in
sarcomagenesis. Clin Cancer Res. 17:416–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miura Y, Keira Y, Ogino J, Nakanishi K,
Noguchi H, Inoue T and Hasegawa T: Detection of specific genetic
abnormalities by fluorescence in situ hybridization in soft tissue
tumors. Pathol Int. 62:16–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iwasaki H, Ishiguro M, Nishio J, Aoki M,
Yokoyama R, Yokoyama K, Taguchi K and Nabeshima K: Extensive
lipoma-like changes of myxoid liposarcoma: Morphologic,
immunohistochemical, and molecular cytogenetic analyses. Virchows
Arch. 466:453–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kraus DH, Dubner S, Harrison LB, Strong
EW, Hajdu SI, Kher U, Begg C and Brennan MF: Prognostic factors for
recurrence and survival in head and neck soft tissue sarcomas.
Cancer. 74:697–702. 1994. View Article : Google Scholar : PubMed/NCBI
|
